Fibrosis Stage-Specific Incidence of Hepatocellular Cancer After Hepatitis C Cure With Direct-Acting Antivirals
![](local/cache-gd2/ce/3a8efc39c4a75cc189ef1757f3e187.jpg?1658182278)
Hepatitis C virus (HCV) eradication with direct-acting antivirals reduces hepatocellular carcinoma (HCC) risk.
A systematic review and meta-analysis, published in Clinical Gastroenterology and Hepatology, assessed HCC incidence or outcomes by cirrhosis status and fibrosis stage, in adults with HCV who achieved sustained virologic response after direct-acting antivirals (DAAs).
The study abstract can be accessed here.